On track to complete enrollment of the chronic cohort in Q2 2024 Data readout from chronic cohort expected in Q3 2024 Planning underway to make NVG-291 available to placebo-treated subjects… Read More
OTTAWA, ON – BioTalent Canada announced the organizations who have distinguished themselves as Inclusion, Diversity, Equity, and Accessibility Leaders through the I.D.E.A.L. Bioscience Employer™ recognition program. The program recognizes health and… Read More
Total net revenue was $45.1 million and $175.5 million, and net product revenue was $42.3 million and $158.5 million, for the fourth quarter and full year 2023, respectively $350.7 million… Read More
Seven talented, early-career scientists in Ontario, Quebec and British Columbia will each receive up to $450,000 over the next three years to support impactful cancer research through the 2024 Terry… Read More
Financing included participation from new and existing investors Pro forma cash and cash equivalents expected to fund current operating plan into 2027 BOSTON, MA & MONTREAL, QC – enGene Holdings Inc…. Read More
